Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9569997rdf:typepubmed:Citationlld:pubmed
pubmed-article:9569997lifeskim:mentionsumls-concept:C0016452lld:lifeskim
pubmed-article:9569997lifeskim:mentionsumls-concept:C0079399lld:lifeskim
pubmed-article:9569997lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:9569997lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:9569997lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9569997lifeskim:mentionsumls-concept:C0533453lld:lifeskim
pubmed-article:9569997lifeskim:mentionsumls-concept:C2827666lld:lifeskim
pubmed-article:9569997pubmed:issue3lld:pubmed
pubmed-article:9569997pubmed:dateCreated1998-6-8lld:pubmed
pubmed-article:9569997pubmed:abstractTextThe objectives of this study were to assess the effect of food and gender on the pharmacokinetics of avitripan. A group of 12 healthy men and 12 healthy women was administered a single 50 mg dose of avitriptan capsule under fasting conditions and 5 min after a high-fat breakfast. The two treatments were repeated in a replicate design to assess the intra-subject variability in the pharmacokinetics of avitriptan under fasted and fed conditions. There was a 1 week washout between treatments. Serial blood samples were collected over 24 h after dosing and analyzed by a validated HPLC method for avitriptan. The mean (SD) peak concentrations (Cmax) were 168 (86.4) ng mL-1 in the fasted condition and 57.3 (34.8) ng mL-1 in the fed condition in males and females combined. The corresponding areas under the plasma concentration curve (AUC) were 335 (162) and 185 (64.5) ng h mL-1, respectively. Both Cmax and AUC were significantly reduced in the fed condition. In addition, the time to peak concentration (tmax) was significantly delayed from a median of 45 min to 2 h after the high-fat breakfast. The clinical significance of this food effect is unclear at the present time. There were no gender differences nor a gender by food interaction in the pharmacokinetics of avitriptan. The intra- and inter-subject variability (%CV) in the Cmax and AUC of avitriptan in the fasted and fed conditions ranged from 10 to 60% in male and female subjects.lld:pubmed
pubmed-article:9569997pubmed:languageenglld:pubmed
pubmed-article:9569997pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:citationSubsetIMlld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9569997pubmed:statusMEDLINElld:pubmed
pubmed-article:9569997pubmed:monthAprlld:pubmed
pubmed-article:9569997pubmed:issn0142-2782lld:pubmed
pubmed-article:9569997pubmed:authorpubmed-author:BarbhaiyaR...lld:pubmed
pubmed-article:9569997pubmed:authorpubmed-author:LeeJ SJSlld:pubmed
pubmed-article:9569997pubmed:authorpubmed-author:GreeneD SDSlld:pubmed
pubmed-article:9569997pubmed:authorpubmed-author:MaratheP HPHlld:pubmed
pubmed-article:9569997pubmed:issnTypePrintlld:pubmed
pubmed-article:9569997pubmed:volume19lld:pubmed
pubmed-article:9569997pubmed:ownerNLMlld:pubmed
pubmed-article:9569997pubmed:authorsCompleteYlld:pubmed
pubmed-article:9569997pubmed:pagination153-7lld:pubmed
pubmed-article:9569997pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:meshHeadingpubmed-meshheading:9569997-...lld:pubmed
pubmed-article:9569997pubmed:year1998lld:pubmed
pubmed-article:9569997pubmed:articleTitleAssessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptan.lld:pubmed
pubmed-article:9569997pubmed:affiliationDepartment of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, Princeton, NJ, USA. Punit_H._Marathe@ccmail.bms.comlld:pubmed
pubmed-article:9569997pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9569997pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9569997pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9569997lld:pubmed